Exocrine pancreatic cancer (e.g., pancreatic ductal adenocarcinoma) has been associated with a daily intake of a high amount of HLD; there is a relationship between Kras mutation, oncogenesis, and inflammation [227]. Here, KRAS is linked to pancreatic ductal adenocarcinoma.